Targeted metabolomic analysis showed that concentrations of arginine, glutamic acid, cysteine, and creatine decreased in response to the inhibitor of lysosomal calcium channel TRPML1 in the cisplatin-resistant cancer cell line and two types of patient-derived ovarian cancer cells. The gene discussed is MCOLN1; the disease is cancer.